A listen to this
Q1 2025 Lantheus Earnings Conference Call
https://investor.lantheus.com/news-events/calendar-of-events
where they discuss their product pipeline and highlights the importance and potential market neurology diagnosis will play going forward
Better and earlier diagnosis open the market for treatment
Lantheus are moving into the space in a big way
https://lantheusholdings.gcs-web.com/news-releases/news-release-details/lantheus-announces-collaboration-provide-novel-tau-imaging-agent
- Forums
- ASX - By Stock
- ATH
- Ann: Alterity Phase 2 Data to be Featured at MSA Congress
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
1.1¢

Ann: Alterity Phase 2 Data to be Featured at MSA Congress, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M |
Open | High | Low | Value | Volume |
1.1¢ | 1.1¢ | 1.1¢ | $9.444K | 869.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
36 | 14901464 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 14444854 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
36 | 14901464 | 0.010 |
28 | 26405228 | 0.009 |
16 | 28051963 | 0.008 |
13 | 4068106 | 0.007 |
15 | 9628518 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 13621777 | 11 |
0.012 | 39126691 | 33 |
0.013 | 9270187 | 17 |
0.014 | 12798180 | 7 |
0.015 | 2059976 | 9 |
Last trade - 11.08am 18/06/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online